
About Manavseva Akshar Diagnostics Private Limited
Data last updated:
Manavseva Akshar Diagnostics Private Limited is a private limited company based in Boisar, Maharashtra, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 30 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85100MH2021PTC370637.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7 Lakh. It is led by directors including Girish Prakash Yevankar and Rhushikesh Arun Patil.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 204 Rooprajat Nagar Palghar District, Boisar, Maharashtra, India – 401501.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.62 Cr, a growth of 57% compared to the previous year. For the same year it recorded a net profit of ₹62.06 Lakh (net margin 17.1%) and EBITDA of ₹1.73 Cr (EBITDA margin 47.8%).
As per MCA filings, the company has open charges of ₹3.44 Cr on record.
For more details, the company can be reached via its website akshardiagnostics.com.
Company details
Contact details
Manavseva Akshar Diagnostics Private Limited's registered office is in Boisar, Maharashtra. Its website is akshardiagnostics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFlat No. 204 Rooprajat Nagar Palghar District, Boisar, Maharashtra, India – 401501
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Manavseva Akshar Diagnostics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Manavseva Akshar Diagnostics is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Manavseva Akshar Diagnostics Private Limited, buy the company report.
Financials of Manavseva Akshar Diagnostics Private Limited
FY 2025 filings availableManavseva Akshar Diagnostics Private Limited reported revenue of ₹3.62 Cr (up 57% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 57% in the latest year. EBITDA rose 59% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.73 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹62.06 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 47.8% | |||
| Net Profit Margin | 17.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Manavseva Akshar Diagnostics Private Limited, buy the company report.
Board of directors of Manavseva Akshar Diagnostics Private Limited
Manavseva Akshar Diagnostics has 7 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Girish Prakash Yevankar Also directs: Shivakshar Imaging Centre LLP, Dombivli Life-Science Private Limited, Akshar Diagnostics Private Limited and 5 more | Director | 30 Oct 2021 | 5 Years 0 Months | Current |
| Rhushikesh Arun Patil | Director | 30 Oct 2021 | 5 Years 0 Months | Current |
| Swapnil Keshavrao Shinde | Director | 03 Aug 2022 | 4 Years 2 Months | Current |
| Ashok Govindbhai Patel | Director | 30 Oct 2021 | 5 Years 0 Months | Current |
| Mahesh Mangaldas Bhanushali | Director | 30 Oct 2021 | 5 Years 0 Months | Current |
| Avinash Ram Pawar | Director | 30 Oct 2021 | 5 Years 0 Months | Current |
Auditor
Manavseva Akshar Diagnostics Private Limited is audited by Sanjay & Snehal for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Sanjay & Snehal | FY 2023 | 118160W |
Shareholding
The shareholding of Manavseva Akshar Diagnostics Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Manavseva Akshar Diagnostics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Sep 2023 | 100802773 | Others | ₹2.34 Cr | Open | |
| 30 Aug 2022 | 100609295 | Yes Bank Limited | ₹1.1 Cr | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Manavseva Akshar Diagnostics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Manavseva Akshar Diagnostics Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 3 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Sanjay & Snehal, Chartered Accountants |
To see the full MSME payment records of Manavseva Akshar Diagnostics Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Manavseva Akshar Diagnostics Private Limited has 1 active EPFO establishment as of Apr 08, 2024.
GST
No GST registration is on our record for Manavseva Akshar Diagnostics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Manavseva Akshar Diagnostics Private Limited has 8 board changes on record since 2021: 7 appointments and 1 cessation. The latest: Swapnil Keshavrao Shinde ceased to be Additional Director on 14 Nov 2022.
1 earlier event is in the company report.
Frequently asked questions
Manavseva Akshar Diagnostics is an active private limited company based in Boisar, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 30 October 2021 (5+ years old) and is registered under CIN U85100MH2021PTC370637.
Manavseva Akshar Diagnostics has 7 current directors:
- Girish Prakash Yevankar - Director
- Rhushikesh Arun Patil - Director
- Swapnil Keshavrao Shinde - Director
- Ashok Govindbhai Patel - Director
- Mahesh Mangaldas Bhanushali - Director
- Avinash Ram Pawar - Director
- Deepak Premanand Patkar - Director
The latest financial statements of Manavseva Akshar Diagnostics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Manavseva Akshar Diagnostics is U85100MH2021PTC370637. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Manavseva Akshar Diagnostics was incorporated on 30 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Swapnil Keshavrao Shinde ceased to be Additional Director on 14 Nov 2022. Swapnil Keshavrao Shinde was appointed as Director on 03 Aug 2022. Ashok Govindbhai Patel was appointed as Director on 30 Oct 2021. Manavseva Akshar Diagnostics has 8 board changes on record in total.
Manavseva Akshar Diagnostics has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 3 overdue payments to 1 micro and small supplier. The latest return was filed on 29 Apr 2024.
Manavseva Akshar Diagnostics can be reached through the website akshardiagnostics.com. Its registered office is in Boisar, Maharashtra, India.
The registered office of Manavseva Akshar Diagnostics is at Flat No. 204 Rooprajat Nagar Palghar District, Boisar, Maharashtra, India – 401501.
Manavseva Akshar Diagnostics operates in the healthcare industry, in the diagnostic centers and pathology labs segment.
Manavseva Akshar Diagnostics has open charges of ₹3.44 Cr and no satisfied charges on record as per latest MCA filings.

